Contents

Current Drug Targets, Volume 7 - Number 3

Editorial [Hot Topic: SMALL MOLECULES OF NATURAL ORIGIN FOR CANCER THERAPY AND CHEMOPREVENTION Part I: Pharmacognosy and Molecular Pharmacology of Small Molecules of Natural Origin for Cancer Therapy and Chemoprevention (Guest Editor: Thomas Efferth )]

, 7(3): 237 - 238

Thomas Efferth


DOI: 10.2174/138945006776054924




Ethnobotany and Ethnopharmacy - Their Role for Anti-Cancer Drug Development

, 7(3): 239 - 245

Michael Heinrich and Paul Bremner


DOI: 10.2174/138945006776054988




The Role of Pharmacognosy in Modern Medicine and Pharmacy

, 7(3): 247 - 264

William P. Jones, Young-Won Chin and A. D. Kinghorn


DOI: 10.2174/138945006776054915




Biodiversity as a Source of Anticancer Drugs

, 7(3): 265 - 277

G. Tan, C. Gyllenhaal and D. D. Soejarto


DOI: 10.2174/138945006776054942




Natural Products from Marine Invertebrates and Microbes as Modulators of Antitumor Targets

, 7(3): 279 - 304

D. J. Newman and G. M. Cragg


DOI: 10.2174/138945006776054960




Antimitotic Agents of Natural Origin

, 7(3): 305 - 326

Advait Nagle, Wooyoung Hur and Nathanael S. Gray


DOI: 10.2174/138945006776054933




Targeting JAK3 and BTK Tyrosine Kinases with Rationally-Designed Inhibitors

, 7(3): 327 - 343

Alexei O. Vassilev, Heather E. Tibbles, Darin DuMez, Taracad K. Venkatachalam and Fatih M. Uckun


DOI: 10.2174/138945006776054997




Natural Flavonoids Targeting Deregulated Cell Cycle Progression in Cancer Cells

, 7(3): 345 - 354

Rana P. Singh and Rajesh Agarwal


DOI: 10.2174/138945006776055004




Natural Product-Based Inhibitors of Hypoxia-Inducible Factor-1 (HIF-1)

, 7(3): 355 - 369

Dale G. Nagle and Yu-Dong Zhou


DOI: 10.2174/138945006776054979




Clinical Aspects of Natural Anti-Angiogenic Drugs

, 7(3): 371 - 383

C. P. Neal, D. P. Berry, H. Doucas, M. M. Manson, W. Steward and G. Garcea


DOI: 10.2174/138945006776054951




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science